NCT01038947View on ClinicalTrials.gov

Safety and Efficacy Study of Intramuscular Uricase-PEG 20

PHASE1UnknownINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

December 31, 2009

Primary Completion Date

April 30, 2010

Study Completion Date

May 31, 2010

Conditions
GoutHyperuricemia
Interventions
BIOLOGICAL

Uricase-PEG 20

Intramuscular injection of Uricase-PEG 20 without premedication

Trial Locations (2)

16635

RECRUITING

Altoona Center for Clinical Research, Duncansville

33143

RECRUITING

MRA Clinical Research, Miami

Sponsors

Lead Sponsor

EnzymeRx
All Listed Sponsors
lead

EnzymeRx

INDUSTRY

NCT01038947 - Safety and Efficacy Study of Intramuscular Uricase-PEG 20 | Biotech Hunter | Biotech Hunter